A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf(Tacrolimus)/ Myfortic and Advagraf (Extended Release Tacrolimus) / Myfortic in de Novo Liver Transplant Recipients.
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2011
At a glance
- Drugs Mycophenolic acid; Tacrolimus
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 05 Oct 2011 Actual end date (December 2010) added as reported by ClinicalTrials.gov.
- 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2010 Preliminary results in 20 patients presented at the 23rd International Congress of the Transplantation Society.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History